Calcium-dependent growth regulation of small cell lung cancer cells by neuropeptides

Endocrine-Related Cancer

Volumn 13, Issue 4, 2006, Pages 1069-1084

  Gudermann, Thomas ^a   Roelle, Susanne ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

5 AMINO 1 [3,5 DICHLORO 4 (4 CHLOROBENZOYL)BENZYL] 1H 1,2,3 TRIAZOLE 4 CARBOXAMIDE; AUTOANTIBODY; BOMBESIN; CISPLATIN; ETOPOSIDE; GASTRIN RELEASING PEPTIDE; GUANINE NUCLEOTIDE BINDING PROTEIN; IMATINIB; MITOGEN ACTIVATED PROTEIN KINASE; NEUROPEPTIDE; PHOSPHOLIPASE C BETA1; PROTEIN KINASE C; STRESS ACTIVATED PROTEIN KINASE; SUBSTANCE P DERIVATIVE;

APOPTOSIS; CALCIUM CELL LEVEL; CALCIUM MOBILIZATION; CALCIUM TRANSPORT; CANCER CELL; CELL DEATH; CELL DIFFERENTIATION; CELL GROWTH; CELL PROLIFERATION; CLINICAL TRIAL; ENZYME ACTIVATION; GROWTH REGULATION; HUMAN; LUNG SMALL CELL CANCER; NONHUMAN; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; CALCIUM; CARCINOMA, SMALL CELL; CELL PROLIFERATION; HUMANS; LUNG NEOPLASMS; NEUROPEPTIDES; RECEPTORS, NEUROPEPTIDE; SIGNAL TRANSDUCTION;

EID: 33846846701     PISSN: 13510088     EISSN: None     Source Type: Journal    
DOI: 10.1677/erc.1.01302     Document Type: Review

References (134)

1. 2+, and calmodulin. Cellular Signalling 14 649-654.
2. Almoguera C, Shibata D, Forrester K, Martin J, Arnheim N & Perucho M 1988 Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes. Cell 53 549-554.
3. Aoto H, Sasaki H, Ishino M & Sasaki T 2002 Nuclear translocation of cell adhesion kinase beta/proline-rich tyrosine kinase 2. Cell Structure and Function 27 47-61.
4. Avraham H, Park SY, Schinkmann K & Avraham S 2000 RAFTK/Pyk2-mediated cellular signalling. Cellular Signalling 12 123-133.
5. Basile JR, Afkhami T & Gutkind JS 2005 Semaphorin 4D/plexin-B1 induces endothelial cell migration through the activation of PYK2, Src, and the phosphatidylinositol 3-kinase-Akt pathway. Molecular and Cellular Biology 25 6889-6898.
6. Beekman A, Helfrich B, Bunn PA, Jr & Heasley LE 1998 Expression of catalytically inactive phospholipase Cβ disrupts phospholipase Cβ and mitogen-activated protein kinase signaling and inhibits small cell lung cancer growth. Cancer Research 58 910-913.
7. Belyanskaya LL, Hopkins-Donaldson S, Kurtz S, Simoes-Wust AP, Yousefi S, Simon HU, Stahel R & Zangemeister-Wittke U 2005 Cisplatin activates Akt in small cell lung cancer cells and attenuates apoptosis by survivin upregulation. International Journal of Cancer 117 755-763.
8. Bernards A 2003 GAPs galore! A survey of putative Ras superfamily GTPase activating proteins in man and Drosophila. Biochimica et Biophysica Acta 1603 47-82.
9. Berridge MJ, Lipp P & Bootman MD 2000 The versatility and universality of calcium signalling. Nature Reviews Molecular Cell biology 1 11-21.
10. Bivona TG, Perez De Castro I, Ahearn IM, Grana TM, Chiu VK, Lockyer PJ, Cullen PJ, Pellicer A, Cox AD & Philips MR 2003 Phospholipase Cγ activates Ras on the Golgi apparatus by means of RasGRP1. Nature 424 694-698.
11. Blaukat A, Ivankovic-Dikic I, Gronroos E, Dolfi F, Tokiwa G, Vuori K & Dikic I 1999 Adaptor proteins Grb2 and Crk couple Pyk2 with activation of specific mitogen-activated protein kinase cascades. Journal of Biological Chemistry 274 14893-14901.
12. 2+ current and TRPV6 channels in lymph node prostate cancer cells. Journal of Biological Chemistry 278 50872-50879.
13. Bonomi P 2002 Matrix metalloproteinases and matrix metalloproteinase inhibitors in lung cancer. Seminars in Oncology 29 78-86.
14. Bos JL, Fearon ER, Hamilton SR, Verlaan-de Vries M, van Boom JH, van der Eb AJ & Vogelstein B 1987 Prevalence of ras gene mutations in human colorectal cancers. Nature 327 293-297.
15. Campbell PM & Der CJ 2004 Oncogenic Ras and its role in tumor cell invasion and metastasis. Seminars in Cancer Biology 14 105-114.
16. Chan DC, Gera L, Stewart JM, Helfrich B, Zhao TL, Feng WY, Chan KK, Covey JM & Bunn PA Jr 2002 Bradykinin antagonist dimer, CU201, inhibits the growth of human lung cancer cell lines in vitro and in vivo and produces synergistic growth inhibition in combination with other antitumor agents. Clinical Cancer Research 8 1280-1287.
17. Chen YL, Law PY & Loh HH 2004 Inhibition of akt/protein kinase B signaling by naltrindole in small cell lung cancer cells. Cancer Research 64 8723-8730.
18. Christodoulou C & Skarlos DV 2005 Treatment of small cell lung cancer. Seminars in Respiratory and Critical Care Medicine 26 333-341.
19. Clapham DE 2003 TRP channels as cellular sensors. Nature 426 517-524.
20. Clark R & Ihde DC 1998 Small-cell lung cancer: treatment progress and prospects. Oncology (Williston Park) 12 647-658 (discussion 661-643).
21. Cook SJ & Lockyer PJ 2006 Recent advances in Ca(2+)-dependent Ras regulation and cell proliferation. Cell Calcium 39 101-112.
22. Cullen PJ & Lockyer PJ 2002 Integration of calcium and Ras signalling. Nature Reviews Molecular Cell biology 3 339-348.
23. Derbyshire ZE, Halfter UM, Heimark RL, Sy TH & Vaillancourt RR 2005 Angiotensin II stimulated transcription of cyclooxygenase II is regulated by a novel kinase cascade involving Pyk2, MEKK4 and annexin II. Molecular and Cellular Biochemistry 271 77-90.
24. Dikic I, Tokiwa G, Lev S, Courtneidge SA & Schlessinger J 1996 A role for Pyk2 and Src in linking G-protein-coupled receptors with MAP kinase activation. Nature 383 547-550.
25. Duncan LM, Deeds J, Hunter J, Shao J, Holmgren LM, Woolf EA, Tepper RI & Shyjan AW 1998 Downregulation of the novel gene melastatin correlates with potential for melanoma metastasis. Cancer Research 58 1515-1520.
26. Dy GK, Miller AA, Mandrekar SJ, Aubry MC, Langdon RM Jr, Morton RF, Schild SE, Jett JR & Adjei AA 2005 A phase II trial of imatinib (STI571) in patients with c-kit expressing relapsed small-cell lung cancer: a CALGB and NCCTG study. Annals of Oncology 16 1811-1816.
27. Ebinu JO, Bottorff DA, Chan EY, Stang SL, Dunn RJ & Stone JC 1998 RasGRP, a Ras guanyl nucleotide-releasing protein with calcium- and diacylglycerol-binding motifs. Science 280 1082-1086.
28. Elrington GM, Murray NM, Spiro SG & Newsom-Davis J 1991 Neurological paraneoplastic syndromes in patients with small cell lung cancer. A prospective survey of 150 patients. Journal of Neurology, Neurosurgery and Psychiatry 54 764-767.
29. Fam NP, Fan WT, Wang Z, Zhang LJ, Chen H & Moran MF 1997 Cloning and characterization of Ras-GRF2, a novel guanine nucleotide exchange factor for Ras. Molecular and Cellular Biology 17 1396-1406.
30. Farnsworth CL, Freshney NW, Rosen LB, Ghosh A, Greenberg ME & Feig LA 1995 Calcium activation of Ras mediated by neuronal exchange factor Ras-GRF. Nature 376 524-527.
31. 2+-selective cation channel TRPV6 in human prostate cancer: a novel prognostic marker for tumor progression. Oncogene 22 7858-7861.
32. Gimond C, van Der Flier A, van Delft S, Brakebusch C, Kuikman I, Collard JG, Fassler R & Sonnenberg A 1999 Induction of cell scattering by expression of β1 integrins in β1-deficient epithelial cells requires activation of members of the rho family of GTPases and downregulation of cadherin and catenin function. Journal of Cell Biology 147 1325-1340.
33. Ginnan R & Singer HA 2002 CaM kinase II-dependent activation of tyrosine kinases and ERK1/2 in vascular smooth muscle. American Journal of Physiology. Cell Physiology 282 C754-C761.
34. Gudermann T 2001 Multiple pathways of ERK activation by G protein-coupled receptors. Novartis Foundation Symposium 239 68-79 (discussion 80-64, 150-159).
35. Gudermann T, Grosse R & Schultz G 2000 Contribution of receptor/G protein signaling to cell growth and transformation. Naunyn-Schmiedeberg's Archives of Pharmacology 361 345-362.
36. Gudermann T, Mederos y Schnitzler M & Dietrich A 2004 Receptor-operated cation entry - more than esoteric terminology? Science's STKE pe35.
37. Halmos G & Schally AV 1997 Reduction in receptors for bombesin and epidermal growth factor in xenografts of human small-cell lung cancer after treatment with bombesin antagonist RC-3095. PNAS 94 956-960.
38. Hancock JF 2003 Ras proteins: different signals from different locations. Nature Reviews Molecular Cell Biology 4 373-384.
39. 2+-permeable channel activated by changes in redox status confers susceptibility to cell death. Molecular Cell 9 163-173.
40. Hartmann TN, Burger JA, Glodek A, Fujii N & Burger M 2005 CXCR4 chemokine receptor and integrin signaling co-operate in mediating adhesion and chemoresistance in small cell lung cancer (SCLC) cells. Oncogene 24 4462-4471.
41. Hatch WC, Ganju RK, Hiregowdara D, Avraham S & Groopman JE 1998 The related adhesion focal tyrosine kinase (RAFTK) is tyrosine phosphorylated and participates in colony-stimulating factor-1/macrophage colony-stimulating factor signaling in monocyte-macrophages. Blood 91 3967-3973.
42. Heasley LE 2001 Autocrine and paracrine signaling through neuropeptide receptors in human cancer. Oncogene 20 1563-1569.
43. Heasley LE, Zamarripa J, Storey B, Helfrich B, Mitchell FM, Bunn PA, Jr & Johnson GL 1996 Discordant signal transduction and growth inhibition of small cell lung carcinomas induced by expression of GTPase-deficient G alpha 16. Journal of Biological Chemistry 271 349-354.
44. i proteins use a novel βγ- and Ras-independent pathway to activate extracellular signal-regulated kinase and mobilize AP-1 transcription factors in Jurkat T lymphocytes. Journal of Biological Chemistry 274 19992-20001.
45. Hildebrand JD, Taylor JM & Parsons JT 1996 An SH3 domain-containing GTPase-activating protein for Rho and Cdc42 associates with focal adhesion kinase. Molecular and Cellular Biology 16 3169-3178.
46. Hofmann T, Obukhov AG, Schaefer M, Harteneck C, Gudermann T & Schultz G 1999 Direct activation of human TRPC6 and TRPC3 channels by diacylglycerol. Nature 397 259-263.
47. 2+-activated monovalent selective cation channel. Current Biology 13 1153-1158.
48. Husgafvel-Pursiainen K 2004 Genotoxicity of environmental tobacco smoke: a review. Mutation Research 567 427-445.
49. Ito T, Udaka N, Yazawa T, Okudela K, Hayashi H, Sudo T, Guillemot F, Kageyama R & Kitamura H 2000 Basic helix-loop-helix transcription factors regulate the neuroendocrine differentiation of fetal mouse pulmonary epithelium. Development 127 3913-3921.
50. Jackson EL, Willis N, Mercer K, Bronson RT, Crowley D, Montoya R, Jacks T & Tuveson DA 2001 Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras. Genes and Development 15 3243-3248.
51. Jaffe AB & Hall A 2002 Rho GTPases in transformation and metastasis. Advances in Cancer Research 84 57-80.
52. Jiang SX, Kameya T, Asamura H, Umezawa A, Sato Y, Shinada J, Kawakubo Y, Igarashi T, Nagai K & Okayasu I 2004 hASH1 expression is closely correlated with endocrine phenotype and differentiation extent in pulmonary neuroendocrine tumors. Modern Pathology 17 222-229.
53. Johnson L, Mercer K, Greenbaum D, Bronson RT, Crowley D, Tuveson DA & Jacks T 2001 Somatic activation of the K-ras oncogene causes early onset lung cancer in mice. Nature 410 1111-1116.
54. Kavanaugh WM, Turck CW, Klippel A & Williams LT 1994 Tyrosine 508 of the 85 kilodalton subunit of phosphatidylinositol 3-kinase is phosphorylated by the platelet-derived growth factor receptor. Biochemistry 33 11046-11050.
55. 2+ channels and phosphoinositide 3-kinase in endothelin-1-induced PYK2 tyrosine phosphorylation. Molecular Pharmacology 63 808-813.
56. Kazanjian A, Wallis D, Au N, Nigam R, Venken KJ, Cagle PT, Dickey BF, Bellen HJ, Gilks CB & Grimes HL 2004 Growth factor independence-1 is expressed in primary human neuroendocrine lung carcinomas and mediates the differentiation of murine pulmonary neuroendocrine cells. Cancer Research 64 6874-6882.
57. Kim JH, Liao D, Lau LF & Huganir RL 1998 SynGAP: a synaptic RasGAP that associates with the PSD-95/SAP90 protein family. Neuron 20 683-691.
58. Kiyohara C, Otsu A, Shirakawa T, Fukuda S & Hopkin JM 2002 Genetic polymorphisms and lung cancer susceptibility: a review. Lung Cancer 37 241-256.
59. Kruljac-Letunic A, Moelleken J, Kallin A, Wieland F & Blaukat A 2003 The tyrosine kinase Pyk2 regulates Arf1 activity by phosphorylation and inhibition of the Arf-GTPase-activating protein ASAP1. Journal of Biological Chemistry 278 29560-29570.
60. Krystal GW, Sulanke G & Litz J 2002 Inhibition of phosphatidylinositol 3-kinase-Akt signaling blocks growth, promotes apoptosis, and enhances sensitivity of small cell lung cancer cells to chemotherapy. Molecular Cancer Therapeutics 1 913-922.
61. Laskin J, Sandler A & Johnson GH 2003 An advance in small-cell lung cancer treatment-more or less. Journal of the National Cancer Institute 95 1099-1101.
62. Lee GY, Jang JS, Lee S Y, Jeon HS, Kim KM, Choi JE, Park JM, Chae MH, Lee WK, Kam S et al. 2005 XPC polymorphisms and lung cancer risk. International Journal of Cancer 115 807-813.
63. Lefkowitz RJ & Shenoy SK 2005 Transduction of receptor signals by β-arrestins. Science 308 512-517.
64. 2+-induced regulation of ion channel and MAP kinase functions. Nature 376 737-745.
65. Lev S, Hernandez J, Martinez R, Chen A, Plowman G & Schlessinger J 1999 Identification of a novel family of targets of PYK2 related to Drosophila retinal degeneration B (rdgB) protein. Molecular and Cellular Biology 19 2278-2288.
66. Lindblad-Toh K, Tanenbaum DM, Daly MJ, Winchester E, Lui WO, Villapakkam A, Stanton SE, Larsson C, Hudson TJ, Johnson BE et al. 2000 Loss-of-heterozygosity analysis of small-cell lung carcinomas using single-nucleotide polymorphism arrays. Nature Biotechnology 18 1001-1005.
67. Litvak V, Tian D, Shaul YD & Lev S 2000 Targeting of PYK2 to focal adhesions as a cellular mechanism for convergence between integrins and G protein-coupled receptor signaling cascades. Journal of Biological Chemistry 275 32736-32746.
68. 2+-dependent inactivation of the Ras-MAPK pathway. Current Biology 11 981-986.
69. bg subunit-mediated activation of mitogen-activated protein kinases. Journal of Biological Chemistry 271 19443-19450.
70. Ma PC, Kijima T, Maulik G, Fox EA, Sattler M, Griffin JD, Johnson BE & Salgia R 2003 c-MET mutational analysis in small cell lung cancer: novel juxtamembrane domain mutations regulating cytoskeletal functions. Cancer Research 63 6272-6281.
71. Mabry M, Nakagawa T, Nelkin BD, McDowell E, Gesell M, Eggleston JC, Casero RA Jr & Baylin SB 1988 v-Ha-ras oncogene insertion: a model for tumor progression of human small cell lung cancer. PNAS 85 6523-6527.
72. Mabry M, Nakagawa T, Baylin S, Pettengill O, Sorenson G & Nelkin B 1989 Insertion of the v-Ha-ras oncogene induces differentiation of calcitonin-producing human small cell lung cancer. Journal of Clinical Investigation 84 194-199.
73. MacKinnon AC, Armstrong RA, Waters CM, Cummings J, Smyth JF, Haslett C & Sethi T 1999 [Arg6,D-Trp7,9,NmePhe8]-substance P (6-11) activates JNK and induces apoptosis in small cell lung cancer cells via an oxidant-dependent mechanism. British Journal of Cancer 80 1026-1034.
74. MacKinnon AC, Waters C, Jodrell D, Haslett C & Sethi T 2001 Bombesin and substance P analogues differentially regulate G-protein coupling to the bombesin receptor. Direct evidence for biased agonism. Journal of Biological Chemistry 276 28083-28091.
75. Maddison P, Newsom-Davis J, Mills KR & Souhami RL 1999 Favourable prognosis in Lambert-Eaton myasthenic syndrome and small-cell lung carcinoma. Lancet 353 117-118.
76. Marinissen MJ & Gutkind JS 2001 G-protein-coupled receptors and signaling networks: emerging paradigms. Trends in Pharmacological Sciences 22 368-376.
77. Maruno K, Absood A & Said SI 1998 Vasoactive intestinal peptide inhibits human small-cell lung cancer proliferation in vitro and in vivo. PNAS 95 14373-14378.
78. Melendez J, Turner C, Avraham H, Steinberg SF, Schaefer E & Sussman MA 2004 Cardiomyocyte apoptosis triggered by RAFTK/Pyk2 via Src kinase is antagonized by paxillin. Journal of Biological Chemistry 279 53516-53523.
79. Meuwissen R, Linn SC, Linnoila RI, Zevenhoven J, Mooi WJ & Berns A 2003 Induction of small cell lung cancer by somatic inactivation of both Trp53 and Rb1 in a conditional mouse model. Cancer Cell 4 181-189.
80. Minna JD, Roth JA & Gazdar AF 2002 Focus on lung cancer. Cancer Cell 1 49-52.
81. Montell C 2005 The TRP superfamily of cation channels. Science STKE re3.
82. Moody TW, Chiles J, Moody E, Sieczkiewicz GJ & Kohn EC 2003 CAI inhibits the growth of small cell lung cancer cells. Lung Cancer 39 279-288.
83. Moore SM, Rintoul RC, Walker TR, Chilvers ER, Haslett C & Sethi T 1998 The presence of a constitutively active phosphoinositide 3-kinase in small cell lung cancer cells mediates anchorage-independent proliferation via a protein kinase B and p70s6k-dependent pathway. Cancer Research 58 5239-5247.
84. Nyeki O, Rill A, Schon I, Orosz A, Schrett J, Bartha L & Nagy J 1998 Synthesis of peptide and pseudopeptide amides inhibiting the proliferation of small cell and epithelial types of lung carcinoma cells. Journal of Peptide Science 4 486-495.
85. 2+/calmodulin-dependent protein kinase II. Journal of Biological Chemistry 279 17980-17988.
86. Orosz A, Schrett J, Nagy J, Bartha L, Schon I & Nyeki O 1995 New short-chain analogs of a substance-P antagonist inhibit proliferation of human small-cell lung-cancer cells in vitro and in vivo. International Journal of Cancer 60 82-87.
87. Paolucci L & Rozengurt E 1999 Protein kinase D in small cell lung cancer cells: rapid activation through protein kinase C. Cancer Research 59 572-577.
88. Parkin DM, Bray FI & Devesa SS 2001 Cancer burden in the year 2000. The global picture. European Journal of Cancer 37 (Suppl 8) S4-S66.
89. Pedersen N, Mortensen S, Sorensen SB, Pedersen MW, Rieneck K, Bovin LF & Poulsen HS 2003 Transcriptional gene expression profiling of small cell lung cancer cells. Cancer Research 63 1943-1953.
90. Pedersen SF, Owsianik G & Nilius B 2005 TRP channels: an overview. Cell Calcium 38 233-252.
91. Pisick E, Jagadeesh S & Salgia R 2004 Receptor tyrosine kinases and inhibitors in lung cancer. Scientific World Journal 4 589-604.
92. Plummer HK III, Dhar MS, Cekanova M & Schuller HM 2005 Expression of G-protein inwardly rectifying potassium channels (GIRKs) in lung cancer cell lines. BMC Cancer 5 104.
93. Prawitt D, Enklaar T, Klemm G, Gartner B, Spangenberg C, Winterpacht A, Higgins M, Pelletier J & Zabel B 2000 Identification and characterization of MTR1, a novel gene with homology to melastatin (MLSN1) and the trp gene family located in the BWS-WT2 critical region on chromosome 11p15.5 and showing allele-specific expression. Human Molecular Genetics 9 203-216.
94. Ravi RK, Weber E, McMahon M, Williams JR, Baylin S, Mal A, Harter ML, Dillehay LE, Claudio PP, Giordano A et al. 1998 Activated Raf-1 causes growth arrest in human small cell lung cancer cells. Journal of Clinical Investigation 101 153-159.
95. Ren XR, Du QS, Huang YZ, Ao SZ, Mei L & Xiong WC 2001 Regulation of CDC42 GTPase by proline-rich tyrosine kinase 2 interacting with PSGAP, a novel pleckstrin homology and Src homology 3 domain containing rhoGAP protein. Journal of Cell Biology 152 971-984.
96. Rodenhuis S, Slebos RJ, Boot AJ, Evers SG, Mooi WJ, Wagenaar SS, van Bodegom PC & Bos JL 1988 Incidence and possible clinical significance of K-ras oncogene activation in adenocarcinoma of the human lung. Cancer Research 48 5738-5741.
97. Rosen LB, Ginty DD, Weber MJ & Greenberg ME 1994 Membrane depolarization and calcium influx stimulate MEK and MAP kinase via activation of Ras. Neuron 12 1207-1221.
98. Rozengurt E 1998 Signal transduction pathways in the mitogenic response to G protein-coupled neuropeptide receptor agonists. Journal of Cellular Physiology 177 507-517.
99. Rozengurt E 1999 Autocrine loops, signal transduction, and cell cycle abnormalities in the molecular biology of lung cancer. Current Opinion in Oncology 11 116-122.
100. Rozengurt E 2002 Neuropeptides as growth factors for normal and cancerous cells. Trends in Endocrinology and Metabolism 13 128-134.
101. Runnels LW, Yue L & Clapham DE 2001 TRP-PLIK, a bifunctional protein with kinase and ion channel activities. Science 291 1043-1047.
102. Schlaepfer DD, Hauck CR & Sieg DJ 1999 Signaling through focal adhesion kinase. Progress in Biophysics and Molecular Biology 71 435-478.
103. Schwindinger WF & Robishaw JD 2001 Heterotrimeric G-protein betagamma-dimers in growth and differentiation. Oncogene 20 1653-1660.
104. Seckl MJ, Higgins T, Widmer F & Rozengurt E 1997 [D-Arg1, D-Trp5,7,9,Leu11]substance P: a novel potent inhibitor of signal transduction and growth in vitro and in vivo in small cell lung cancer cells. Cancer Research 57 51-54.
105. Sethi T, Langdon S, Smyth J & Rozengurt E 1992 Growth of small cell lung cancer cells: stimulation by multiple neuropeptides and inhibition by broad spectrum antagonists in vitro and in vivo. Cancer Research 52 2737s-2742s.
106. Sethi T, Rintoul RC, Moore SM, MacKinnon AC, Salter D, Choo C, Chilvers ER, Dransfield I, Donnelly SC, Strieter R et al. 1999 Extracellular matrix proteins protect small cell lung cancer cells against apoptosis: a mechanism for small cell lung cancer growth and drug resistance in vivo. Nature Medicine 5 662-668.
107. q-coupled receptors by increasing the duration of ERK signaling in swiss 3T3 cells. Journal of Biological Chemistry 279 16883-16893.
108. Sipma H, Deelman L, Smedt HD, Missiaen L, Parys JB, Vanlingen S, Henning RH & Casteels R 1998 Agonist-induced down-regulation of type 1 and type 3 inositol 1,4,5-trisphosphate receptors in A7r5 and DDT1 MF-2 smooth muscle cells. Cell Calcium 23 11-21.
109. Soria JC, Johnson BE & Chevalier TL 2003 Imatinib in small cell lung cancer. Lung Cancer 41 (Suppl 1) S49-S53.
110. Sutton I & Winer JB 2002 The immunopathogenesis of paraneoplastic neurological syndromes. Clinical Science (London) 102 475-486.
111. 2+-permeable cationic channels in LNCaP human prostate cancer epithelial cells. Journal of Physiology 548 823-836.
112. Thakker GD, Hajjar DP, Muller WA & Rosengart TK 1999 The role of phosphatidylinositol 3-kinase in vascular endothelial growth factor signaling. Journal of Biological Chemistry 274 10002-10007.
113. 2+-permeable cationic channels in prostate cancer epithelial cells. Journal of Clinical Investigation 111 1691-1701.
114. Tokman MG, Porter RA & Williams CL 1997 Regulation of cadherin-mediated adhesion by the small GTP-binding protein Rho in small cell lung carcinoma cells. Cancer Research 57 1785-1793.
115. Travis WD 2002 Pathology of lung cancer. Clinics in Chest Medicine 23 65-81, viii.
116. Tsavaler L, Shapero MH, Morkowski S & Laus R 2001 Trp-p8, a novel prostate-specific gene, is up-regulated in prostate cancer and other malignancies and shares high homology with transient receptor potential calcium channel proteins. Cancer Research 61 3760-3769.
117. Tsuda T, Kusui T, Hou W, Benya RV, Akeson MA, Kroog GS, Battey JF & Jensen RT 1997 Effect of gastrin-releasing peptide receptor number on receptor affinity, coupling, degradation, and modulation. Molecular Pharmacology 51 721-732.
118. Tsurutani J, West KA, Sayyah J, Gills JJ & Dennis PA 2005 Inhibition of the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin pathway but not the MEK/ERK pathway attenuates laminin-mediated small cell lung cancer cellular survival and resistance to imatinib mesylate or chemotherapy. Cancer Research 65 8423-8432.
119. Ueda H, Abbi S, Zheng C & Guan JL 2000 Suppression of Pyk2 kinase and cellular activities by FIP200. Journal of Cell Biology 149 423-430.
120. Varker KA, Phelps SH, King MM & Williams CL 2003 The small GTPase RhoA has greater expression in small cell lung carcinoma than in non-small cell lung carcinoma and contributes to their unique morphologies. International Journal of Oncology 22 671-681.
121. 2+. FEBS Letters 546 6-10.
122. Wang S, Bruzzi J, Rodriguez-Garza VP & Komaki RR 2006 Lambert-Eaton myasthenic syndrome in a patient with small-cell lung cancer. Clinical Lung Cancer 7 282-284.
123. Watkins DN, Berman DM, Burkholder SG, Wang B, Beachy PA & Baylin SB 2003 Hedgehog signalling within airway epithelial progenitors and in small-cell lung cancer. Nature 422 313-317.
124. Williams CL 1997 Basic science of small cell lung cancer. Chest Surgery Clinics of North America 7 1-19.
125. Wissenbach U, Niemeyer BA, Fixemer T, Schneidewind A, Trost C, Cavalie A, Reus K, Meese E, Bonkhoff H & Flockerzi V 2001 Expression of CaT-like, a novel calcium-selective channel, correlates with the malignancy of prostate cancer. Journal of Biological Chemistry 276 19461-19468.
126. Wistuba II, Gazdar AF & Minna JD 2001 Molecular genetics of small cell lung carcinoma. Seminars in Oncology 28 3-13.
127. Wittau N, Grosse R, Kalkbrenner F, Gohla A, Schultz G & Gudermann T 2000 The galanin receptor type 2 initiates multiple signaling pathways in small cell lung cancer cells by coupling to G(q), G(i) and G(12) proteins. Oncogene 19 4199-4209.
128. Wojcikiewicz RJ, Furuichi T, Nakade S, Mikoshiba K & Nahorski SR 1994 Muscarinic receptor activation downregulates the type I inositol 1,4,5-trisphosphate receptor by accelerating its degradation. Journal of Biological Chemistry 269 7963-7969.
129. 2+, PKC, and Rho kinase. American Journal of Physiology. Cell Physiology 282 C1432-C1444.
130. βγ-dependent pathway that involves phosphoinositide 3-kinase and Akt. Journal of Biological Chemistry 275 24907-24914.
131. Xiong W & Parsons JT 1997 Induction of apoptosis after expression of PYK2, a tyrosine kinase structurally related to focal adhesion kinase. Journal of Cell Biology 139 529-539.
132. Xiong WC, Macklem M & Parsons JT 1998 Expression and characterization of splice variants of PYK2, a focal adhesion kinase-related protein. Journal of Cell Science 111 (Pt 14) 1981-1991.
133. Zhang L & Barritt GJ 2006 TRPM8 in prostate cancer cells: a potential diagnostic and prognostic marker with a secretory function? Endocrine-Related Cancer 13 27-38.
134. Zwick E, Daub H, Aoki N, Yamaguchi-Aoki Y, Tinhofer I, Maly K & Ullrich A 1997 Critical role of calcium-dependent epidermal growth factor receptor transactivation in PC12 cell membrane depolarization and bradykinin signaling. Journal of Biological Chemistry 272 24767-24770.